Damian Fiore

Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis

Benjamin Turner, Bruce Cree, Ludwig Kappos et al. · Journal of Neurology · 2019 · 84 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial

Edward Fox, Clyde Markowitz, Angela Applebee et al. · Multiple Sclerosis Journal · 2018 · 52 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +15

Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients

Akhil Bhalla, Ritesh Ravi, Meng Fang et al. · International Journal of Molecular Sciences · 2020 · 30 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial

Douglas L. Arnold, Peter A. Calabresi, Bernd C. Kieseier et al. · BMC Neurology · 2017 · 25 citations · Full text

Medicine, Neurology, Pharmacotherapy +14

A feasibility study of a manualized resilience-based telehealth program for persons with multiple sclerosis and their support partners

Elizabeth J. Halstead, Victoria M. Leavitt, Damian Fiore et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 2020 · 24 citations · Full text

Public Health, Rehabilitation Medicine, Neurorehabilitation +15